| Source Date | Board Meeting Date | Details |
|
16-Apr-2025
|
23-Apr-2025
|
Stock Split
|
|
03-Apr-2025
|
11-Apr-2025
|
Final Dividend (Revised) & Audited Results Due to unavoidable circumstances, the Meeting of Board of Directors which was scheduled to be held on Friday, 4t April, 2025 is now postponed and re-scheduled on Friday, 11t April,2025, inter alia to: 1. Audited Financial Results of the Company for the Quarter & Year ended on 315t March, 2025. 2. Proposal of Final Dividend on the equity shares of the Company for the Financial Year 2024-25, subject to the approval of shareholders in the ensuing Annual General Meeting. 3. Any other business with the permission of the Chair.
|
|
20-Mar-2025
|
04-Apr-2025
|
Final Dividend & Audited Results
|
|
15-Jan-2025
|
24-Jan-2025
|
Bonus issue
|
|
03-Jan-2025
|
09-Jan-2025
|
Quarterly Results
|
|
18-Nov-2024
|
27-Nov-2024
|
Bonus Issue Inter alia, to consider and transact the following businesses: 1. The proposal for issue of Bonus Shares to the equity shareholders of the Company, subject to shareholders approval; 2. To adopt new set of Memorandum of Association; 3. To adopt a new set of Articles of Association for the company; 4. To Finalize time, date and venue to convene the Extra Ordinary General Meeting of the Company; 5. To Finalize the dates of Book Closure, Record Rate/ Cut-off Date and E- voting related matter for the purpose of forthcoming Extra Ordinary General Meeting; 6. To Appoint of Mr. Ashish Goyal, Proprietor of M/s A. Goyal & Associates and Company Secretary in Whole-time Practice as a Scrutinizer ascertain Voting process of Extra Ordinary General Meeting of the company; 7. Any other matter with the permission of chair.
|
|
30-Oct-2024
|
13-Nov-2024
|
Interim Dividend
|
|
01-Oct-2024
|
07-Oct-2024
|
Quarterly Results
|
|
17-Sep-2024
|
21-Sep-2024
|
Inter alia, to consider and approve:- 1. To Increase the authorised share capital of the Company, subject to necessary approvals. 2. To consider and evaluate for raising of funds through issue of equity shares and/or any other eligible securities, including but not limited to warrants, depository receipts, FCCBs or any combination thereof or securities representing equity shares or convertible into or exchangeable for equity shares, through preferential issue, qualified institutions placement, rights issue, ADR, GDR, FCCB or such other permissible mode or combination thereof, as may be considered appropriate, subject to the approval of the members of the Company, and other regulatory and/or statutory approvals, as applicable. 3. Any other Business with the permission of chair and majority of directors.
|
|
23-Jul-2024
|
26-Jul-2024
|
Quarterly Results
|